Benison Keung

Dr. Benison Keung is an Associate Professor of Neurology at Yale University School of Medicine, specializing in neuromuscular medicine. With expertise in peripheral neuropathy, myasthenia gravis, and muscle disorders, he provides comprehensive care for patients with complex neurological conditions. His clinical approach emphasizes thorough evaluation and patient-centered medicine within Yale's collaborative academic environment.

Education:

• MD, New York Medical College (2008)
• BA in Biochemistry, New York University (2003)
• Residency, Yale-New Haven Hospital (2012)
• Fellowship, Yale-New Haven Hospital (2013)

Dr. Keung's research focuses on the cause, progression, and management of peripheral neuropathy syndromes, primary muscle disorders, and disorders of neuromuscular transmission. He actively works to bridge clinical care with basic science in neuromuscular disorders, with particular emphasis on myasthenia gravis and treatment innovations. His work often involves collaborative multicenter studies examining novel therapeutics for refractory neuromuscular conditions.

Analysis of Dr. Keung's recent publications reveals a strong focus on myasthenia gravis treatment, particularly the use of eculizumab and other complement inhibitors. His work also addresses chemotherapy-induced neuropathies and diagnostic antibody testing in chronic inflammatory neuropathies. The research demonstrates a consistent theme of translating clinical observations into practical treatment approaches for complex neuromuscular disorders.

Board Certifications:

• Neurology (American Board of Psychiatry & Neurology, 2012)
• Neuromuscular Medicine (American Board of Psychiatry & Neurology, 2014)

Dr. Keung is actively involved in clinical research through the Nowak Lab at Yale, collaborating with experts including Dr. Richard Nowak, Dr. Huned Patwa, and Dr. Daniel DiCapua. His work frequently appears in high-impact neurology journals, reflecting his contributions to advancing treatment protocols for challenging neuromuscular conditions. He serves on multiple clinical trials examining novel therapeutics for myasthenia gravis and peripheral neuropathies.

As part of Yale's Neuromuscular Medicine division, Dr. Keung contributes to the Myasthenia Gravis Program and Neurophysiology services. His clinical work is integrated with research initiatives aimed at improving diagnostic accuracy and treatment outcomes for patients with complex neuromuscular disorders.